PT  - JOURNAL ARTICLE
AU  - Cunningham, Muriel
ED  - Qureshi, Adnan I.
TI  - Insights from the ATACH Trial
DP  - 2008 May 01
TA  - MD Conference Express
PG  - 9--9
VI  - 8
IP  - 1
4099  - http://mdc.sagepub.com/content/8/1/9.short
4100  - http://mdc.sagepub.com/content/8/1/9.full
AB  - What is the most appropriate treatment of acute hypertensive response after intracerebral hemorrhage? Over time, two schools of thought have emerged: one that thinks blood pressure should not be treated because hematoma expansion is uncommon and perihematoma ischemia is a concern, and one that takes the opposite position. The goal of the open-label Antihypertensive Treatment of Acute Cerebral Hemorrhage trial [ATACH] was to determine the tolerability and safety of three different systolic blood pressure goals using IV nicardipine.